These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31206512)

  • 21. Anti-human erythrocyte antibodies in horse-derived antivenoms used in the treatment of snakebite envenomations.
    León G; Rodríguez MA; Rucavado A; Lomonte B; Gutiérrez JM
    Biologicals; 2007 Mar; 35(1):5-11. PubMed ID: 16490363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced pepsin digestion: a novel process for purifying antibody F(ab')(2) fragments in high yield from serum.
    Jones RG; Landon J
    J Immunol Methods; 2002 May; 263(1-2):57-74. PubMed ID: 12009204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical assessment of immunoreactivity of a new purified equine F(ab')2 against European viper venom.
    Pepin-Covatta S; Lutsch C; Lang J; Scherrmann JM
    J Pharm Sci; 1998 Feb; 87(2):221-5. PubMed ID: 9519157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Venoms, antivenoms and immunotherapy.
    Chippaux JP; Goyffon M
    Toxicon; 1998 Jun; 36(6):823-46. PubMed ID: 9663690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Refinement and Neutralization Evaluation of the F(ab')
    Li R; Yu H; Li A; Yu C; Li P
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa.
    Gutiérrez JM; Rojas E; Quesada L; León G; Núñez J; Laing GD; Sasa M; Renjifo JM; Nasidi A; Warrell DA; Theakston RD; Rojas G
    Trans R Soc Trop Med Hyg; 2005 Jun; 99(6):468-75. PubMed ID: 15837359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical evaluation of caprylic acid-fractionated IgG antivenom for the treatment of Taipan (Oxyuranus scutellatus) envenoming in Papua New Guinea.
    Vargas M; Segura A; Herrera M; Villalta M; Estrada R; Cerdas M; Paiva O; Matainaho T; Jensen SD; Winkel KD; León G; Gutiérrez JM; Williams DJ
    PLoS Negl Trop Dis; 2011 May; 5(5):e1144. PubMed ID: 21610854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal conditions for the preparation of Fab and F(ab')2 fragments from monoclonal IgG of different rat IgG subclasses.
    Rousseaux J; Rousseaux-Prévost R; Bazin H
    J Immunol Methods; 1983 Nov; 64(1-2):141-6. PubMed ID: 6644029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification and stability studies of immunoglobulins from Lachesis muta muta antivenom.
    Rodrigues-Silva R; Martins MS; Magalhães A; Santoro MM
    Toxicon; 1997 Aug; 35(8):1229-38. PubMed ID: 9278972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roughness of Production Conditions: Does It Really Affect Stability of IgG-Based Antivenoms?
    Mateljak Lukačević S; Kurtović T; Borić J; Halassy B
    Toxins (Basel); 2022 Jul; 14(7):. PubMed ID: 35878221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A protocol for 'enhanced pepsin digestion': a step by step method for obtaining pure antibody fragments in high yield from serum.
    Jones RG; Landon J
    J Immunol Methods; 2003 Apr; 275(1-2):239-50. PubMed ID: 12667687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study on the ability of IgG and F(ab')2 antivenoms to neutralize lethal and myotoxic effects induced by Micrurus nigrocinctus (coral snake) venom.
    León G; Stiles B; Alape A; Rojas G; Gutiérrez JM
    Am J Trop Med Hyg; 1999 Aug; 61(2):266-71. PubMed ID: 10463678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-rabies immunoglobulin preparation based on F(ab')2 fragments].
    Nikiforov AK; Volokh OA; Lobovikova OA; Diatlov IA; Zhulidov IM
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (1):72-4. PubMed ID: 17523436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of the first effective hyperimmune equine serum antivenom against Africanized bees.
    Santos KS; Stephano MA; Marcelino JR; Ferreira VM; Rocha T; Caricati C; Higashi HG; Moro AM; Kalil JE; Malaspina O; Castro FF; Palma MS
    PLoS One; 2013; 8(11):e79971. PubMed ID: 24236166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human heterophilic antibodies against equine immunoglobulins: assessment of their role in the early adverse reactions to antivenom administration.
    León G; Segura A; Herrera M; Otero R; França FO; Barbaro KC; Cardoso JL; Wen FH; de Medeiros CR; Prado JC; Malaque CM; Lomonte B; Gutiérrez JM
    Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1115-9. PubMed ID: 18561967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental manufacture of equine antivenom against yamakagashi (Rhabdophis tigrinus).
    Morokuma K; Kobori N; Fukuda T; Uchida T; Sakai A; Toriba M; Ohkuma K; Nakai K; Kurata T; Takahashi M
    Jpn J Infect Dis; 2011; 64(5):397-402. PubMed ID: 21937821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caprylic acid fractionation of hyperimmune horse plasma: description of a simple procedure for antivenom production.
    Rojas G; Jiménez JM; Gutiérrez JM
    Toxicon; 1994 Mar; 32(3):351-63. PubMed ID: 8016856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Report of a WHO workshop on the standardization and control of antivenoms.
    Theakston RD; Warrell DA; Griffiths E
    Toxicon; 2003 Apr; 41(5):541-57. PubMed ID: 12676433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-step purification of F(ab')2 mu fragments of mouse monoclonal antibodies (immunoglobulins M) by hydrophobic interaction high-performance liquid chromatography using TSKgel ether-5PW.
    Inouye K; Morimoto K
    J Biochem Biophys Methods; 1993 Feb; 26(1):27-39. PubMed ID: 8482788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Snake F(ab')2 antivenom from hyperimmunized horse: pharmacokinetics following intravenous and intramuscular administrations in rabbits.
    Pepin S; Lutsch C; Grandgeorge M; Scherrmann JM
    Pharm Res; 1995 Oct; 12(10):1470-3. PubMed ID: 8584483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.